Perforin gene variant A91V in young patients with severe COVID-19

類似資料

• The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
  著者:: Cabrera-Marante, Oscar, 等
  出版事項: (2020)
• T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
  著者:: Gil-Etayo, Francisco Javier, 等
  出版事項: (2021)
• IL-6–based mortality risk model for hospitalized patients with COVID-19
  著者:: Laguna-Goya, Rocio, 等
  出版事項: (2020)
• Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
  著者:: Pleguezuelo, Daniel E., 等
  出版事項: (2021)
• Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome
  著者:: Oscar Cabrera-Marante, 等
  出版事項: (2025-08-01)